BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cong PF, Qu YC, Chen JP, Duan LL, Lin CJ, Zhu XL, Li-Ling J, Zhang MX. Growth inhibition and apoptosis induction by alternol in pancreatic carcinoma cells. World J Gastroenterol 2015; 21(15): 4526-4535 [PMID: 25914461 DOI: 10.3748/wjg.v21.i15.4526]
URL: https://www.wjgnet.com/1007-9327/full/v21/i15/4526.htm
Number Citing Articles
1
Yuqiong Lin, Ying Xu, Xin Zheng, Jingwen Zhang, Junfeng Liu, Guotu Wu. Astragaloside IV Ameliorates Streptozotocin Induced Pancreatic β-Cell Apoptosis and Dysfunction Through SIRT1/P53 and Akt/GSK3β/Nrf2 Signaling PathwaysDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 131 doi: 10.2147/DMSO.S347650
2
Mostafa Vaghari‐Tabari, Gordon A. Ferns, Durdi Qujeq, Ali Nosrati Andevari, Zahra Sabahi, Soheila Moein. Signaling, metabolism, and cancer: An important relationship for therapeutic interventionJournal of Cellular Physiology 2021; 236(8): 5512 doi: 10.1002/jcp.30276
3
Wang Liu, Jean C. Li, Jian Huang, Jiepeng Chen, Jeffrey Holzbeierlein, Benyi Li. Alternol/Alteronol: Potent Anti-cancer Compounds With Multiple Mechanistic ActionsFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.568110
4
J. Lv, X. Wang, S.Y. Liu, P.F. Liang, M. Feng, L.L. Zhang, A.P. Xu. Protective effect of Fenofibrate in renal ischemia reperfusion injury: Involved in suppressing kinase 2 (JAK2)/transcription 3 (STAT3)/p53 signaling activationPathologie Biologie 2015; 63(6): 236 doi: 10.1016/j.patbio.2015.07.010
5
Wang Chunli, Zhang Liang, Wu Meimei, Jing Yuntiao, Lai Xiaoping, Huang Song, Zhang Xiaojun. Antioxidative and hepatoprotective activities of the ethyl acetate fraction separated from the fruit of Livistona chinensisJournal of Traditional Chinese Medicine 2018; 38(4): 523 doi: 10.1016/S0254-6272(18)30884-7
6
Ewelina Zielinska, Agata Zauszkiewicz-Pawlak, Michal Wojcik, Iwona Inkielewicz-Stepniak. Silver nanoparticles of different sizes induce a mixed type of programmed cell death in human pancreatic ductal adenocarcinomaOncotarget 2018; 9(4): 4675 doi: 10.18632/oncotarget.22563